Acute Kidney Injury in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic: Experience From PICUs Across United Kingdom.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 13 10 2020
medline: 22 12 2020
entrez: 12 10 2020
Statut: ppublish

Résumé

To study the prevalence, evolution, and clinical factors associated with acute kidney injury in children admitted to PICUs with pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2. Multicenter observational study. Fifteen PICUs across the United Kingdom. Patients admitted to United Kingdom PICUs with pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2 between March 14, 2020, and May 20, 2020. None. Deidentified data collected as part of routine clinical care were analyzed. All children were diagnosed and staged for acute kidney injury based on the level of serum creatinine above the upper limit of reference interval values according to published guidance. Severe acute kidney injury was defined as stage 2/3 acute kidney injury. Uni- and multivariable analyses were performed to study the association between demographic data, clinical features, markers of inflammation and cardiac injury, and severe acute kidney injury. Over the study period, 116 patients with pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2 were admitted to 15 United Kingdom PICUs. Any-stage acute kidney injury occurred in 48 of 116 patients (41.4%) and severe acute kidney injury in 32 of 116 (27.6%) patients, which was mostly evident at admission (24/32, 75%). In univariable analysis, body mass index, hyperferritinemia, high C-reactive protein, Pediatric Index of Mortality 3 score, vasoactive medication, and invasive mechanical ventilation were associated with severe acute kidney injury. In multivariable logistic regression, hyperferritinemia was associated with severe acute kidney injury (compared with nonsevere acute kidney injury; adjusted odds ratio 1.04; 95% CI, 1.01-1.08; p = 0.04). Severe acute kidney injury was associated with longer PICU stay (median 5 days [interquartile range, 4-7 d] vs 3 days [interquartile range, 1.5-5 d]; p < 0.001) and increased duration of invasive mechanical ventilation (median 4 days [interquartile range, 2-6 d] vs 2 days [interquartile range, 1-3 d]; p = 0.04). Severe acute kidney injury occurred in just over a quarter of children admitted to United Kingdom PICUs with pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2. Hyperferritinemia was significantly associated with severe acute kidney injury. Severe acute kidney injury was associated with increased duration of stay and ventilation. Although short-term outcomes for acute kidney injury in pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2 appear good, long-term outcomes are unknown.

Identifiants

pubmed: 33044282
doi: 10.1097/CCM.0000000000004662
pii: 00003246-202012000-00013
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1809-1818

Subventions

Organisme : Department of Health
ID : CS-2015-15-016
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Références

World Health OrganizationDirector-General’s Remarks at the Media Briefing on 2019-nCoV on 11 February 2020. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. Accessed February 12, 2020.
Zimmermann P, Curtis N: Coronavirus infections in children including COVID-19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020; 39:355–368.
Royal College of Paediatrics and Child Health: Guidance - Paediatric Multisystem Inflammatory Syndrome Temporally Associated With COVID-19.Available at: https://www.rcpch.ac.uk/resources/guidance-paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims. Accessed May 21, 2020.
Centers for Disease Control and PreventionMultisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease 2019 (COVID-19). Available at: https://emergency.cdc.gov/han/2020/han00432.asp. Accessed May 21, 2020.
WHO PublicationMultisystem Inflammatory Syndrome in Children and Adolescents With COVID-19. Available at: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Accessed May 21, 2020.
Riphagen S, Gomez X, Gonzalez-Martinez C, et al.: Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395:1607–1608.
Viner RM, Whittaker E: Kawasaki-like disease: Emerging complication during the COVID-19 pandemic. Lancet. 2020; 395:1741–1743.
Whittaker E, Bamford A, Kenny J, et al.; PIMS-TS Study Group and EUCLIDS and PERFORM Consortia: Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020; 324:259–269.
Verdoni L, Mazza A, Gervasoni A, et al.: An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020; 395:1771–1778.
Toubiana J, Poirault C, Corsia A, et al.: Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: Prospective observational study. BMJ. 2020369m2094.
Belhadjer Z, Méot M, Bajolle F, et al.: Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS CoV-2 pandemic. Circulation. 2020; 382:1370–1422.
Ramcharan T, Nolan O, Lai CY, et al.: Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): Cardiac features, management and short-term outcomes at a UK tertiary paediatric Hospital. Pediatr Cardiol. 2020 Jun 12. [online ahead of print].
Schneider J, Khemani R, Grushkin C, et al.: Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit. Crit Care Med. 2010; 38:933–939.
Akcan-Arikan A, Zappitelli M, Loftis LL, et al.: Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007; 71:1028–1035.
Kaddourah A, Basu RK, Bagshaw SM, et al.; AWARE Investigators: Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med. 2017; 376:11–20.
Chuang GT, Tsai IJ, Lin MT, et al.: Acute kidney injury in patients with Kawasaki disease. Pediatr Res. 2016; 80:224–227.
Chen T, Wu D, Chen H, et al.: Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ. 2020; 368:m1091.
Yang X, Yu Y, Xu J, et al.: Clinical course and outcomes of critically ill patients with SARSCoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8:475–481.
Hirsch JS, Ng JH, Ross DW, et al.; Northwell COVID-19 Research Consortium; Northwell Nephrology COVID-19 Research Consortium: Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020; 98:209–218.
Straney L, Clements A, Parslow RC, et al.; ANZICS Paediatric Study Group and the Paediatric Intensive Care Audit Network: Paediatric index of mortality 3: An updated model for predicting mortality in pediatric intensive care*. Pediatr Crit Care Med. 2013; 14:673–681.
Think Kidneys, UK Renal Registry: Guidance for Clinicians Managing Children at Risk of, or With Acute Kidney Injury.Available at: https://www.thinkkidneys.nhs.uk/aki/wp-content/uploads/sites/2/2019/12/AKI-Guidance-paediatric-patients-Dec2019.pdf. Accessed May 21, 2020.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Inter, Suppl. 2012; 2:1–138.
Lederer DJ, Bell SC, Branson RD, et al.: Control of confounding and reporting of results in causal inference studies. Guidance for authors from Editors of Respiratory, Sleep, and Critical Care Journals. Ann Am Thorac Soc. 2019; 16:22–28.
Davies P, Evans C, Kanthimathinathan HK, et al.: Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: A multicentre observational study. Lancet Child Adolesc Health. 2020; 4:669–677.
Stewart DJ, Hartley JC, Johnson M, et al.: Renal dysfunction in hospitalised children with COVID-19. Lancet Child Adolesc Health. 2020; 4:e28–e29.
Sprague AH, Khalil RA: Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol. 2009; 78:539–552.
Devarajan P: Updates on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006; 17:1503–1520.
Goldstein SL, Mottes T, Simpson K, et al.: A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int. 2016; 90:212–221.
Friedewald JJ, Rabb H: Inflammatory cells in ischemic acute renal failure. Kidney Int. 2004; 66:486–491.
Li Y, Wang J, Bai Z, et al.: Early fluid overload is associated with acute kidney injury and PICU mortality in critically ill children. Eur J Pediatr. 2016; 175:39–48.
Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011; 121:4210–4221.
Liu L, Wei Q, Lin Q, et al.: Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 2019; 4:S6.
Deep A, Sagar H, Goonasekera C, et al.: Evolution of acute kidney injury and its association with systemic hemodynamics in children with fluid-refractory septic shock. Crit Care Med. 2018; 46:e677–e683.
Jetton JG, Boohaker LJ, Sethi SK, et al.; Neonatal Kidney Collaborative (NKC): Incidence and outcomes of neonatal acute kidney injury (AWAKEN): A multicentre, multinational, observational cohort study. Lancet Child Adolesc Health. 2017; 1:184–194.
Fitzgerald JC, Basu RK, Akcan-Arikan A, et al.; Sepsis PRevalence, OUtcomes, and Therapies Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators Network: Acute kidney injury in pediatric severe sepsis: An independent risk factor for death and new disability. Crit Care Med. 2016; 44:2241–2250.
Li S, Krawczeski CD, Zappitelli M, et al.; TRIBE-AKI Consortium: Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: A prospective multicenter study. Crit Care Med. 2011; 39:1493–1499.
Lal BB, Alam S, Sood V, et al.: Profile, risk factors and outcome of acute kidney injury in paediatric acute-on-chronic liver failure. Liver Int. 2018; 38:1777–1784.
Gatterre P, Oualha M, Dupic L, et al.: Kawasaki disease: An unexpected etiology of shock and multiple organ dysfunction syndrome. Intensive Care Med. 2012; 38:872–878.
Koh KN, Sunkara A, Kang G, et al.: Acute kidney injury in pediatric patients receiving allogeneic hematopoietic cell transplantation: Incidence, risk factors, and outcomes. Biol Blood Marrow Transplant. 2018; 24:758–764.
Levin M, Holland PC, Nokes TJ, et al.: Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis. Br Med J (Clin Res Ed). 1985; 290:1456–1460.
Menikou S, Langford PR, Levin M: Kawasaki disease: The role of immune complexes revisited. Front Immunol. 2019; 10:1156.
Basu RK, Zappitelli M, Brunner L, et al.: Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int. 2014; 85:659–667.
Gross O, Moerer O, Weber M, et al.: COVID-19-associated nephritis: Early warning for disease severity and complications? Lancet. 2020; 395:e87–e88.
Husain-Syed F, Slutsky AS, Ronco C: Lung-kidney cross-talk in the critically ill patient. Am J Respir Crit Care Med. 2016; 194:402–414.
Sharkey RA, Mulloy EM, O’Neill SJ: The acute effects of oxygen and carbon dioxide on renal vascular resistance in patients with an acute exacerbation of COPD. Chest. 1999; 115:1588–1592.
Danziger J, Chen KP, Lee J, et al.: Obesity, acute kidney injury, and mortality in critical illness. Crit Care Med. 2016; 44:328–334.
Dimitrijevic ZM, Salinger-Martinovic SS, Jankovic RJ, et al.: Elevated serum ferritin levels are predictive of renal function recovery among patients with acute kidney injury. Tohoku J Exp Med. 2019; 248:63–71.
Glanzmann C, Frey B, Vonbach P, et al.: Drugs as risk factors of acute kidney injury in critically ill children. Pediatr Nephrol. 2016; 31:145–151.
Alkandari O, Eddington KA, Hyder A, et al.: Acute kidney injury is an independent risk factor for pediatric intensive care unit mortality, longer length of stay and prolonged mechanical ventilation in critically ill children: A two-center retrospective cohort study. Crit Care. 2011; 15:R146.
Bailey D, Phan V, Litalien C, et al.: Risk factors of acute renal failure in critically ill children: A prospective descriptive epidemiological study. Pediatr Crit Care Med. 2007; 8:29–35.

Auteurs

Akash Deep (A)

Pediatric Intensive Care Unit, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, United Kingdom.

Gaurang Upadhyay (G)

Pediatric Intensive Care Unit, King's College Hospital NHS Foundation Trust, London, United Kingdom.

Pascale du Pré (P)

Pediatric Intensive Care Unit, Great Ormond Street Hospital, London, United Kingdom.

Jon Lillie (J)

Pediatric Intensive Care Unit, Evelina Children's Hospital, London, United Kingdom.

Daniel Pan (D)

Department of Respiratory Sciences, University of Leicester, Leicester, United Kingdom.

Nadeesha Mudalige (N)

UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Hari Krishnan Kanthimathinathan (HK)

Pediatric Intensive Care Unit, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom.

Mae Johnson (M)

Pediatric Intensive Care Unit, Great Ormond Street Hospital, London, United Kingdom.

Shelley Riphagen (S)

Pediatric Intensive Care Unit, Evelina Children's Hospital, London, United Kingdom.

Buvana Dwarakanathan (B)

Pediatric Intensive Care Unit, St George's Hospital, London, United Kingdom.

Dusan Raffaj (D)

Pediatric Critical Care Unit, Nottingham Children's Hospital, Nottingham, United Kingdom.

Santosh Sundararajan (S)

Pediatric Intensive Care Unit, Leeds Children's Hospital, Leeds, United Kingdom.

Patrick Davies (P)

Pediatric Critical Care Unit, Nottingham Children's Hospital, Nottingham, United Kingdom.

Zoha Mohammad (Z)

Pediatric Intensive Care Unit, Leicester Royal Infirmary, Leicester, United Kingdom.

Nayan Shetty (N)

Pediatric Intensive Care Unit, Alder Hey Children's Hospital, Liverpool, United Kingdom.

Stephen Playfor (S)

Pediatric Intensive Care Unit, Royal Manchester Children's Hospital, Manchester, United Kingdom.

Michelle Jardine (M)

Pediatric Critical Care Unit, Children's Hospital for Wales, Cardiff, United Kingdom.

Oliver Ross (O)

Pediatric Intensive Care Unit, Southampton Children's Hospital, Southampton, United Kingdom.

Richard Levin (R)

Pediatric Intensive Care Unit, Royal Hospital for Children, Glasgow, United Kingdom.

Gareth Waters (G)

Pediatric Intensive Care Unit, Evelina Children's Hospital, London, United Kingdom.

Ruchi Sinha (R)

Pediatric Intensive Care Unit, St Mary's Hospital, London, United Kingdom.

Barnaby R Scholefield (BR)

Pediatric Intensive Care Unit, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom.
Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.

Elizabeth Boot (E)

Pediatric Intensive Care Unit, Evelina Children's Hospital, London, United Kingdom.

Ashwani Koul (A)

Pediatric Critical Care Unit, John Radcliffe Hospital, Oxford, United Kingdom.

Xabier Freire-Gomez (X)

Pediatric Intensive Care Unit, Evelina Children's Hospital, London, United Kingdom.

Padmanabhan Ramnarayan (P)

Pediatric Intensive Care Unit, St Mary's Hospital, London, United Kingdom.
Children's Acute Transport Service, Great Ormond Street Hospital NHS Foundation Trust and NIHR Biomedical Research Centre, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH